as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹177.39
Change
+0.0 (0.0%)
Open
₹177.39
Prev. Close
₹177.39
Day High
₹177.87
Day Low
₹176.03
Volume Analysis
Traded
68,281
Delivered
46,747
Delivery %
68.46%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹180.01 | ₹178.94 | ₹178.17 | ₹177.1 | ₹176.33 | ₹175.26 | ₹174.49 |
| Fibonacci | ₹178.94 | ₹178.24 | ₹177.8 | ₹177.1 | ₹176.4 | ₹175.96 | ₹175.26 |
| Camarilla | ₹177.9 | ₹177.73 | ₹177.56 | ₹177.1 | ₹177.22 | ₹177.05 | ₹176.88 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+18.5%
1 Week
-0.25%
1 Month
+12.29%
3 Months
+5.27%
6 Months
+10.44%
1 Year
+16.76%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Icicipramc - Icicipharm holds up reasonably well on TopFund's composite fundamentals check, at 70/100. The strongest factor is Risk & Volatility (87/100), while Liquidity (50/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
70/100 — GoodData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc - Icicipharm?
Frequently Asked Questions about Icicipramc - Icicipharm
Icicipramc - Icicipharm (HEALTHIETF) closed at ₹177.39 on NSE on 19 November 2026, up 0.0 (0.0%) from the previous close.
Icicipramc - Icicipharm trades on the NSE (National Stock Exchange of India) under the symbol HEALTHIETF.
Icicipramc - Icicipharm has a TopFund Quality Score of 70/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc - Icicipharm?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.